En Es

Industry News

Global Visualization Instruments for MIS Market Driven by Increasing Demand for Endoscopy Procedures

By HospiMedica International staff writers
23 Nov 2022

Image: The global visualization instruments for MIS market is estimated to surpass USD 21 billion by 2031 (Photo courtesy of Pexels)

The last few years have witnessed an increase in patient preference for medical surgeries that involve fewer incisions. As a result, the demand for visualization instruments, which aid in achieving improved patient outcomes and help healthcare personnel perform examinations efficiently, has increased, thereby driving the growth of the global visualization instruments for minimally invasive surgery (MIS) market. Moreover, the leading market players are investing in research and development to introduce improved visualization systems that can meet the requirements of healthcare infrastructure facilities such as hospitals and clinics.

The increasing demand for visualization systems for complex surgical procedures, growing demand for minimally invasive surgeries, and rising prevalence of chronic diseases are expected to help the global visualization instruments for MIS market register a CAGR of 7.2% between 2022 and 2031 and reach a value of USD 21 billion by 2031. The increasing usage of robotics while performing medical procedures for greater precision and reduced human intervention are anticipated to further fuel market growth during the forecast period.

These are the latest findings of Transparency Market Research (Wilmington, DE, USA), a global market research company.

Based on product type, the visualization systems segment accounted for the largest share of the visualization instruments for MIS market in 2021 and is expected to maintain its dominant position during the forecast period. The rise in technological advancements in visualization systems for minimally invasive surgeries aimed at improving imaging capacities, coupled with the launch of a growing number of new visualization systems is contributing to the segment’s growth.

Based on consumables & accessories, the endoscopy MIS segment accounted for a major share of the visualization instruments for MIS market in 2021 due to an increasing number of endoscopy procedures and rising adoption of visualization instruments and MIS instruments in endoscopy medical procedures, worldwide. Based on end-use, the hospital end-use segment held the largest share of the visualization instruments for MIS market in 2021, due to an increasing number of minimally invasive surgeries performed in hospitals, as well as a rise in number of hospitals globally.

Geographically, Europe accounted for major share of the visualization instruments for MIS market in 2021 due to increasing demand for minimally invasive surgeries and rising prevalence of chronic diseases in European countries such as the U.K. and Germany. The visualization instruments for MIS market in Latin America is expected to witness significant growth during the forecast period owing to its increasing geriatric population and growing awareness about minimally invasive surgeries in Latin American countries such as Brazil and Argentina.

Related Links:
Transparency Market Research

E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

11 Nov 2022
Global Diagnostic ECG Market Driven by Increased Incidence of Cardiac Diseases
The rising prevalence of such chronic conditions is necessitating the need for diagnosis and treatment in order to keep track of the patient's daily medical condition and maintain medical records. This, coupled with rising hospitalization of the older population for the treatment of cardiac diseases, has increased the need for electrocardiograph (ECG) diagnosis.
Read More
11 Nov 2022
Radcal to Supply Quality Assurance X-Ray Testing Equipment to West Physics
Radcal Corporation (Monrovia, CA, USA), a leading manufacturer of diagnostic X-ray quality assurance (QA) meters, has reached an agreement with West Physics (Atlanta, GA, USA), one of the largest and most successful Medical Physics groups in the U.S., to supply QA X-ray testing equipment.
Read More
09 Nov 2022
Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling
Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining panels, tissue staining, and imaging and analysis services.
Read More
08 Nov 2022
Global Infusion Pumps Market Driven by Increasing Incidence of Chronic Diseases
Rising demand for ambulatory infusion pumps in home care, increasing incidence of chronic diseases along with a rapid growth of the geriatric population, and growing number of surgical procedures being performed, are driving the growth of the global infusion pumps market. As a result, the market is projected to register a CAGR of 7% from USD 14.7 billion in 2022 to USD 20.5 billion by 2027.
Read More
07 Nov 2022
Mast Group Enters into Multi-Country Distribution Agreement for Nanomix's eLab System
Mast Group Limited (Liverpool, UK) and Nanomix (Emeryville, CA, USA) have entered into a multi-region distribution agreement wherein Mast will market and distribute the Nan?mix eLab system in the UK, Germany, France, Ireland and South Africa.
Read More
07 Nov 2022
AI-Enabled Diagnostic Testing Could Become More Accurate and Reliable than Current Tests
An expanded collaboration between two industry leaders will pave the way for the development of AI-enabled diagnostic testing that is more accurate and reliable than current U.S. tests for patients with chronic diseases, including kidney, cardiovascular, liver and neurologic conditions.
Read More
01 Nov 2022
Global Infectious Respiratory Disease Diagnostics Market Driven by New Multiplex PCR Tests and POC Products
The global infectious respiratory disease diagnostics market size is expected to reach USD 43.6 billion by 2030, driven by an increase in the prevalence of infectious respiratory diseases and initiatives taken by governments & non-profit organizations to introduce novel & innovative products to address the growing demand.
Read More
01 Nov 2022
Johnson & Johnson to Acquire Cardiovascular Technology Company Abiomed in USD 16.6 Billion Deal
Johnson & Johnson (New Brunswick, N.J., USA) has entered into a definitive agreement to acquire all outstanding shares of Abiomed, Inc. (Danvers, MA, USA) in a deal valued at approximately USD 16.6 billion which includes cash acquired.
Read More
01 Nov 2022
Global Endoscopic Imaging Systems Market Driven by Increasing Adoption of AI and Minimally Invasive Procedures
The global endoscopic imaging systems market was valued at USD 3.64 billion in 2021 and is expected to grow at a CAGR of 7.43% during the forecast period 2022-2030 to reach USD 6.94 billion by 2030.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions